A Phase 2 Study on Effect of Thymosin Beta 4 on Wound Healing in Patients With Epidermolysis Bullosa

Clinical trial NCT00311766 · TERMINATED

Trial details

NCT number: NCT00311766
Sponsor: RegeneRx Biopharmaceuticals, Inc.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Epidermolysis Bullosa

Start date: 2006-02-01
Primary completion: 2010-07-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.